These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 12577241)
21. The potential role of amifostine in the treatment of carcinoma of the uterine cervix: a review. Small W Semin Radiat Oncol; 2002 Jan; 12(1 Suppl 1):68-74. PubMed ID: 11917288 [TBL] [Abstract][Full Text] [Related]
22. Incidence and temporal pattern of anorexia, diarrhea, weight loss, and leukopenia in patients with cervical cancer treated with concurrent radiation therapy and weekly cisplatin: comparison with radiation therapy alone. Ohno T; Kato S; Wakatsuki M; Noda SE; Murakami C; Nakamura M; Tsujii H Gynecol Oncol; 2006 Oct; 103(1):94-9. PubMed ID: 16527337 [TBL] [Abstract][Full Text] [Related]
23. Chemoprotective and radioprotective effects of amifostine: an update of clinical trials. Capizzi RL; Oster W Int J Hematol; 2000 Dec; 72(4):425-35. PubMed ID: 11197208 [TBL] [Abstract][Full Text] [Related]
24. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. Eifel PJ; Winter K; Morris M; Levenback C; Grigsby PW; Cooper J; Rotman M; Gershenson D; Mutch DG J Clin Oncol; 2004 Mar; 22(5):872-80. PubMed ID: 14990643 [TBL] [Abstract][Full Text] [Related]
26. Randomized phase III trial of postoperative radiochemotherapy +/- amifostine in head and neck cancer. Is there evidence for radioprotection? Vacha P; Fehlauer F; Mahlmann B; Marx M; Hinke A; Sommer K; Richter E; Feyerabend T Strahlenther Onkol; 2003 Jun; 179(6):385-9. PubMed ID: 12789464 [TBL] [Abstract][Full Text] [Related]
27. Open label multicenter trial of subcutaneous amifostine (Ethyol) in the prevention of radiation induced esophagitis and pneumonitis in patients with measurable, unresectable non-small cell lung cancer. Mehta V Semin Oncol; 2004 Dec; 31(6 Suppl 18):42-6. PubMed ID: 15726522 [TBL] [Abstract][Full Text] [Related]
29. Phase II study of radiation therapy combined with weekly nedaplatin in locally advanced uterine cervical carcinoma: Kitasato Gynecologic Radiation Oncology Group (KGROG 0501). Niibe Y; Hayakawa K; Tsunoda S; Kanai T; Imai M; Arai M; Arai T; Kawaguchi M; Jobo T; Hamada Y; Yago K; Unno N; Jpn J Clin Oncol; 2007 Jan; 37(1):70-2. PubMed ID: 17204507 [TBL] [Abstract][Full Text] [Related]
30. Protection of normal tissues from the cytotoxic effects of radiation therapy: focus on amifostine. Mehta MP Semin Radiat Oncol; 1998 Oct; 8(4 Suppl 1):14-6. PubMed ID: 9794996 [TBL] [Abstract][Full Text] [Related]
31. Concurrent weekly cisplatin and radiotherapy in routine management of cervical cancer: a report on patient compliance and acute toxicity. Serkies K; Jassem J Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):814-21. PubMed ID: 15465198 [TBL] [Abstract][Full Text] [Related]
32. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer. Rao GG; Rogers P; Drake RD; Nguyen P; Coleman RL Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596 [TBL] [Abstract][Full Text] [Related]
33. Comparison of treatment tolerance and outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy in a prospective randomized trial or with standard treatment. Torres MA; Jhingran A; Thames HD; Levenback CF; Bodurka DC; Ramondetta LM; Eifel PJ Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):118-25. PubMed ID: 17869451 [TBL] [Abstract][Full Text] [Related]
34. Radioprotective effect of amifostine in patients with head and neck squamous cell carcinoma. Bourhis J; Rosine D Semin Oncol; 2002 Dec; 29(6 Suppl 19):61-2. PubMed ID: 12577247 [TBL] [Abstract][Full Text] [Related]
35. A retrospective review of 15 years of radical radiotherapy with or without concurrent cisplatin and/or 5-fluorouracil for the treatment of locally advanced cervical cancer. Borowsky ME; Elliott KS; Pezzullo JC; Santoso P; Choi W; Choi K; Abulafia O Bull Cancer; 2005 Feb; 92(2):E19-24. PubMed ID: 15749639 [TBL] [Abstract][Full Text] [Related]
36. Can the use of amifostine improve cure rates for patients with advanced non-small cell lung cancer? Rosenman J Semin Oncol; 2004 Dec; 31(6 Suppl 18):52-8. PubMed ID: 15726524 [TBL] [Abstract][Full Text] [Related]
37. Concurrent weekly cisplatin plus external beam radiotherapy and high-dose rate brachytherapy for advanced cervical cancer: a control cohort comparison with radiation alone on treatment outcome and complications. Chen SW; Liang JA; Hung YC; Yeh LS; Chang WC; Lin WC; Yang SN; Lin FJ Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1370-7. PubMed ID: 16979836 [TBL] [Abstract][Full Text] [Related]
38. The role of amifostine as a radioprotector. Wasserman TH; Brizel DM Oncology (Williston Park); 2001 Oct; 15(10):1349-54; discussion 1357-60. PubMed ID: 11702962 [TBL] [Abstract][Full Text] [Related]
39. Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study. Lanciano R; Calkins A; Bundy BN; Parham G; Lucci JA; Moore DH; Monk BJ; O'Connor DM J Clin Oncol; 2005 Nov; 23(33):8289-95. PubMed ID: 16230678 [TBL] [Abstract][Full Text] [Related]
40. A pilot Phase II trial of concurrent radiotherapy, chemotherapy, and hyperthermia for locally advanced cervical carcinoma. Jones EL; Samulski TV; Dewhirst MW; Alvarez-Secord A; Berchuck A; Clarke-Pearson D; Havrilesky LJ; Soper J; Prosnitz LR Cancer; 2003 Jul; 98(2):277-82. PubMed ID: 12872345 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]